Strides Pharma Science
BSE 532531
2 stories, newest first.
- Strides Pharma schedules Q2FY27 earnings call on October 30, 2026 at 10:00 hrs IST for investors and analysts
- Board meeting on October 29, 2026 to consider and approve unaudited results for Q2 and H1
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.